バイオマテリアルの世界市場レポート 2025年

バイオマテリアルの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR14.4％で2,625億6,000万米ドルに成長します。この予測期間における成長は、消費者の嗜好の変化、3Dプリントやアディティブマニュファクチャリングにおけるバイオマテリアル需要の急増、生分解性・生体吸収性バイオマテリアルセグメントの拡大、個別化医療のためのドラッグデリバリーシステムにおけるバイオマテリアルの採用、創傷治療や組織再生におけるバイオマテリアルの使用増加などに起因しています。予測期間における主要動向としては、応答性と適応性を備えたスマートバイオマテリアルの開発、機能性向上のためのナノテクノロジーの統合、カスタマイズされたバイオマテリアルソリューションにつながる精密医療の重視、海洋および植物由来のバイオマテリアル供給源の探求、革新的な用途のためのバイオマテリアル企業とヘルスケア機関のコラボレーションなどが挙げられます。

心血管疾患の有病率の増加は、バイオマテリアル市場の拡大を促進しています。心血管疾患は、高血圧、喫煙、高コレステロール、運動不足などの要因に起因します。心血管疾患患者の増加は、糖尿病、慢性呼吸器疾患、冠動脈疾患（CAD）、高血圧に関連する心臓発作などの非伝染性疾患に大きく起因しています。心臓弁、心肺バイパスシステム、ステント、人工血管、人工心臓、ペースメーカーなどのバイオマテリアルは、損傷したり病気になったりした心臓組織の治癒メカニズムとして機能します。例えば、米国の政府機関である疾病管理予防センター（CDC）の2024年5月のデータによると、2022年に米国で心臓病による死亡者は70万2,880人で、そのうち37万1,506人が冠動脈疾患に起因しています。その結果、心血管疾患の罹患率の上昇がバイオマテリアル市場の需要を押し上げると予想されます。

ヘルスケア支出の増加はバイオマテリアル市場の成長を促進します。ヘルスケア支出とは、一定期間内に医療サービス、治療、ヘルスケアインフラに割り当てられる総財源を指し、一般的には国または機関レベルで行われます。ヘルスケア支出は、バイオマテリアルにおいて研究開発、製品開発、調達、採用、規制遵守に使用されます。例えば2022年9月、ベルギーを拠点とする欧州の医療技術業界を代表する業界団体MedTech Europeによると、欧州では平均して国内総生産（GDP）の約11％がヘルスケアに割り当てられています。このうち約7.6％が医療技術に充てられています。欧州各国の医療技術への支出は、ヘルスケア総支出の約5％から12％です。欧州の医療技術に対する一人当たりの支出は約346.08ドル（284ユーロ）です。したがって、ヘルスケア支出の増加は、バイオマテリアル市場の成長に貢献すると思われます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のバイオマテリアル市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のバイオマテリアル市場の成長率分析
• 世界のバイオマテリアル市場の実績：規模と成長、2019～2024年
• 世界のバイオマテリアル市場の予測：規模と成長、2024～2029年、2034年
• 世界のバイオマテリアル総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオマテリアル市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 金属バイオマテリアル
• ポリマーバイオマテリアル
• 天然バイオマテリアル
• セラミック
• 世界のバイオマテリアル市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 心臓血管
• 整形外科
• 眼科
• 歯科
• 形成外科
• 創傷治癒
• 組織工学
• 神経系/中枢神経系
• 世界のバイオマテリアル市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院・クリニック
• 外来手術センター
• その他のエンドユーザー
• 世界のバイオマテリアル市場：金属バイオマテリアルのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ステンレス鋼
• チタン合金
• コバルトクロム合金
• マグネシウム合金
• 世界のバイオマテリアル市場：ポリマーバイオマテリアルのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 合成ポリマー
• 天然ポリマー
• 生分解性ポリマー
• 世界のバイオマテリアル市場：天然バイオマテリアルのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 動物由来原料
• 植物由来原料
• 世界のバイオマテリアル市場：セラミックのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• バイオセラミック
• 多孔質セラミック
• 非多孔質セラミック

第7章 地域別・国別分析

• 世界のバイオマテリアル市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のバイオマテリアル市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオマテリアル市場：競合情勢
• バイオマテリアル市場：企業プロファイル
  • Corbion N V Overview, Products and Services, Strategy and Financial Analysis
  • Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • Heraeus Medical Components LLC Overview, Products and Services, Strategy and Financial Analysis
  • Berkeley Advanced Biomaterials Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• DSM Biomedical BV
• PolyNovo Limited
• Baxter International Inc.
• Stryker Corporation
• Collagen Solutions plc
• Invibio Ltd.
• Aap Implantate AG
• Cam Bioceramics BV
• CeramTec GmbH
• CoorsTek Medical LLC
• CryoLife Inc.
• Cerapedics Inc.
• Surmodics Inc.
• Secant Group LLC
• GELITA AG

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バイオマテリアル市場2029年-最も新しい機会を提供する国
• バイオマテリアル市場2029年-最も新しい機会を提供するセグメント
• バイオマテリアル市場2029年-成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The biomaterials refer to manmade substances that can be utilized to support tissues or structures in the body. These are natural or synthetic materials that are used in medical applications to support, enhance, or replace damaged tissue or a biological function.

The main types of biomaterials are metallic biomaterial, polymeric biomaterials, natural biomaterials and ceramics. The metallic biomaterials are stainless steels, titanium alloys, and cobalt alloys used to provide internal support to biological tissues. The metallic biomaterials are manmade systems that are utilized in joint replacements, dental implants, orthopedic fixations, and stents to offer internal support to biological tissues. Biomaterials have a wide application in cardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering and neurological/central nervous system and are used in hospitals and clinics, ambulatory surgical centers and other end users.

The biomaterials market research report is one of a series of new reports from The Business Research Company that provides biomaterials market statistics, including biomaterials industry global market size, regional shares, competitors with a biomaterials market share, detailed biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the biomaterials industry. This biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biomaterials market size has grown rapidly in recent years. It will grow from $134.31 billion in 2024 to $153.55 billion in 2025 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to growing aging population, adoption of biomaterials in orthopedic and dental applications, increasing awareness of environmental sustainability, increased prevalence of chronic conditions medicine, increased demand for medical implants.

The biomaterials market size is expected to see rapid growth in the next few years. It will grow to $262.56 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to shifting consumer preferences, surge in demand for biomaterials in 3d printing and additive manufacturing, expansion of the biodegradable and bioresorbable biomaterials segment, adoption of biomaterials in drug delivery systems for personalized medicine, increasing use of biomaterials in wound care and tissue regeneration. Major trends in the forecast period include development of smart biomaterials with responsive and adaptive properties, integration of nanotechnology for enhanced functionality, emphasis on precision medicine leading to customized biomaterial solutions, exploration of marine and plant-derived biomaterial sources, collaboration between biomaterial companies and healthcare institutions for innovative applications.

The growing prevalence of cardiovascular diseases is propelling the expansion of the biomaterials market. Cardiovascular disorders stem from factors such as high blood pressure, smoking, high cholesterol, and inactivity. The rise in cardiovascular disorder cases is largely attributed to noncommunicable diseases like diabetes, chronic respiratory illnesses, coronary artery disease (CAD), and heart attacks related to hypertension. Biomaterials, including heart valves, cardiopulmonary bypass systems, stents, vascular grafts, complete artificial hearts, and pacemakers, serve as healing mechanisms for damaged and diseased heart tissue. For instance, data from the Centers for Disease Control and Prevention (CDC), a US government agency, indicated in May 2024 that there were 702,880 deaths from heart disease in the United States in 2022, with 371,506 of those attributable to coronary artery disease. Consequently, the rising incidence of cardiovascular diseases is expected to boost the demand for the biomaterials market.

The increasing healthcare spending will propel the growth of the biomaterials market. Healthcare spending refers to the total financial resources allocated for medical services, treatments, and healthcare infrastructure within a given period, typically on a national or institutional level. Healthcare spending is used in biomaterials for research and development, product development, procurement and adoption, and regulatory compliance. For instance, in September 2022, according to MedTech Europe, a Belgium-based European trade association representing the medical technology industries, in Europe, on average, approximately 11% of gross domestic product (GDP) is allocated to healthcare. Out of this, about 7. 6% is attributed to medical technologies. The spending on medical technology across European countries ranges from around 5% to 12% of the total healthcare expenditure. The per capita expenditure on medical technology in Europe stands at approximately $346. 08 (€284). Therefore, increasing healthcare spending will contribute to the growth of the biomaterials market.

Strategic partnerships are emerging as a significant trend in the biomaterials market. Leading companies are increasingly focusing on collaborations to develop new implants and combination devices based on biomaterials, leveraging each other's expertise, technology, and resources. These partnerships also aim to boost the adoption of biomaterials. By joining forces, companies can gain a competitive advantage in the market and enhance revenue. For example, in June 2023, IFF, a US-based corporation, launched the Designed Enzymatic Biomaterials (DEB) technology platform to meet the rising demand for sustainable, high-performance materials. This platform enables precise drug delivery through engineered enzymes that release therapeutic agents in response to specific biological cues. It is also vital in tissue engineering, where enzymatic reactions promote tissue regeneration by facilitating cell growth and allowing controlled degradation of scaffolds at predetermined rates. The DEB technology enables the customization of biobased polysaccharides that can match or surpass the performance of traditional petroleum-based polymers, thereby facilitating greater market adoption.

Major companies operating in the biomaterials market focus on technological advancements, such as the designed enzymatic biomaterials (DEB) technology platform, to deliver sustainable biopolymers and gain a competitive advantage. The enzymatic biomaterials (DEB) technology platform involves the use of enzymes to design and modify materials for various applications, including drug delivery, tissue engineering, and diagnostics. For instance, in June 2023, International Flavors & Fragrances Inc., a US-based producer of flavors, fragrances, and cosmetic actives, launched the enzymatic biomaterials technology platform for the development of biobased materials at scale. Designed to deliver meaningful sustainability benefits with performance comparable to or superior to fossil-based materials, DEB technology helps to address growing preferences for environmentally friendly, high-performance biopolymers. The technology platform allows producers to fulfill regulatory changes and increasing consumer demand by replacing traditional fossil-based synthetic polymers.

In October 2024, RTI Surgical (RTI), a US-based medical equipment manufacturing company, acquired Collagen Solutions plc for an undisclosed amount. The objective of RTI Surgical's acquisition of Collagen Solutions is to broaden its soft tissue portfolio and improve its capabilities in the regenerative medicine sector. Collagen Solutions plc is a US-based supplier, developer, and manufacturer of medical-grade collagen, tissues, and other biomaterials for use in regenerative medicine, medical devices, and research.

Major companies operating in the biomaterials market include Corbion N V, Evonik Industries AG, Heraeus Medical Components LLC, Berkeley Advanced Biomaterials Inc., Zimmer Biomet Holdings Inc., DSM Biomedical BV, PolyNovo Limited, Baxter International Inc., Stryker Corporation, Collagen Solutions plc, Invibio Ltd., Aap Implantate AG, Cam Bioceramics BV, CeramTec GmbH, CoorsTek Medical LLC, CryoLife Inc., Cerapedics Inc., Surmodics Inc., Secant Group LLC, GELITA AG, Quattroflow GmbH, Kyocera Corporation, Wright Medical Group NV, KLS Martin Group GmbH & Co KG, Meccellis Biotechnology Co Ltd., Bio-on SpA, Coloplast A/S, Collagen Matrix Inc., IntrinsiQ Materials Inc., PolyActiva Pty Ltd

North America was the largest region in the biomaterials market in 2024. The regions covered in the biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The biomaterials market consists of sales of metals, polymers, and composites. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biomaterials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biomaterials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Metallic Biomaterial; Polymeric Biomaterials; Natural Biomaterials; Ceramics
• 2) By Application: Cardiovascular; Orthopedic; Ophthalmology; Dental; Plastic Surgery; Wound Healing; Tissue Engineering; Neurological/Central Nervous System
• 3) By End Use: Hospitals And Clinics; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Metallic Biomaterials: Stainless Steel; Titanium Alloys; Cobalt-Chromium Alloys; Magnesium Alloys
• 2) By Polymeric Biomaterials: Synthetic Polymers; Natural Polymers; Biodegradable Polymers
• 3) By Natural Biomaterials: Animal-Derived Materials; Plant-Derived Materials
• 4) By Ceramics: Bioceramics; Porous Ceramics; Non-porous Ceramics
• Companies Mentioned: Corbion N V; Evonik Industries AG; Heraeus Medical Components LLC; Berkeley Advanced Biomaterials Inc.; Zimmer Biomet Holdings Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biomaterials Market Characteristics

3. Biomaterials Market Trends And Strategies

4. Biomaterials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Biomaterials Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biomaterials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biomaterials Market Growth Rate Analysis
• 5.4. Global Biomaterials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biomaterials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biomaterials Total Addressable Market (TAM)

6. Biomaterials Market Segmentation

• 6.1. Global Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metallic Biomaterial
• Polymeric Biomaterials
• Natural Biomaterials
• Ceramics
• 6.2. Global Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular
• Orthopedic
• Ophthalmology
• Dental
• Plastic Surgery
• Wound Healing
• Tissue Engineering
• Neurological/Central Nervous System
• 6.3. Global Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Other End Users
• 6.4. Global Biomaterials Market, Sub-Segmentation Of Metallic Biomaterials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stainless Steel
• Titanium Alloys
• Cobalt-Chromium Alloys
• Magnesium Alloys
• 6.5. Global Biomaterials Market, Sub-Segmentation Of Polymeric Biomaterials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Polymers
• Natural Polymers
• Biodegradable Polymers
• 6.6. Global Biomaterials Market, Sub-Segmentation Of Natural Biomaterials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Animal-Derived Materials
• Plant-Derived Materials
• 6.7. Global Biomaterials Market, Sub-Segmentation Of Ceramics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioceramics
• Porous Ceramics
• Non-porous Ceramics

7. Biomaterials Market Regional And Country Analysis

• 7.1. Global Biomaterials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biomaterials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biomaterials Market

• 8.1. Asia-Pacific Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biomaterials Market

• 9.1. China Biomaterials Market Overview
• 9.2. China Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biomaterials Market

• 10.1. India Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biomaterials Market

• 11.1. Japan Biomaterials Market Overview
• 11.2. Japan Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biomaterials Market

• 12.1. Australia Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biomaterials Market

• 13.1. Indonesia Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biomaterials Market

• 14.1. South Korea Biomaterials Market Overview
• 14.2. South Korea Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biomaterials Market

• 15.1. Western Europe Biomaterials Market Overview
• 15.2. Western Europe Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biomaterials Market

• 16.1. UK Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biomaterials Market

• 17.1. Germany Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biomaterials Market

• 18.1. France Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biomaterials Market

• 19.1. Italy Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biomaterials Market

• 20.1. Spain Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biomaterials Market

• 21.1. Eastern Europe Biomaterials Market Overview
• 21.2. Eastern Europe Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biomaterials Market

• 22.1. Russia Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biomaterials Market

• 23.1. North America Biomaterials Market Overview
• 23.2. North America Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biomaterials Market

• 24.1. USA Biomaterials Market Overview
• 24.2. USA Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biomaterials Market

• 25.1. Canada Biomaterials Market Overview
• 25.2. Canada Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biomaterials Market

• 26.1. South America Biomaterials Market Overview
• 26.2. South America Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biomaterials Market

• 27.1. Brazil Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biomaterials Market

• 28.1. Middle East Biomaterials Market Overview
• 28.2. Middle East Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biomaterials Market

• 29.1. Africa Biomaterials Market Overview
• 29.2. Africa Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biomaterials Market Competitive Landscape And Company Profiles

• 30.1. Biomaterials Market Competitive Landscape
• 30.2. Biomaterials Market Company Profiles
  • 30.2.1. Corbion N V Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Heraeus Medical Components LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Berkeley Advanced Biomaterials Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Biomaterials Market Other Major And Innovative Companies

• 31.1. DSM Biomedical BV
• 31.2. PolyNovo Limited
• 31.3. Baxter International Inc.
• 31.4. Stryker Corporation
• 31.5. Collagen Solutions plc
• 31.6. Invibio Ltd.
• 31.7. Aap Implantate AG
• 31.8. Cam Bioceramics BV
• 31.9. CeramTec GmbH
• 31.10. CoorsTek Medical LLC
• 31.11. CryoLife Inc.
• 31.12. Cerapedics Inc.
• 31.13. Surmodics Inc.
• 31.14. Secant Group LLC
• 31.15. GELITA AG

32. Global Biomaterials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biomaterials Market

34. Recent Developments In The Biomaterials Market

35. Biomaterials Market High Potential Countries, Segments and Strategies

• 35.1 Biomaterials Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biomaterials Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biomaterials Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer